Review paper
Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside
Abstract
Hepatitis C virus (HCV) infection and its complications have been the major cause of cirrhosis and its complications for several decades in the Western world. Until recently, treatment for HCV with interferon-based regimens was associated with moderate success but was difficult to tolerate. More recently, however, an arsenal of novel and highly effective direct-acting antiviral (DAA) drugs has transformed the landscape by curing HCV in a broad...
Paper Details
Title
Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside
Published Date
Apr 1, 2021
Journal
Volume
160
Issue
5
Pages
1502 - 1520.e1
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History